Nippon Express (China) Participates in 11th Global Pharmaceutical Cold Chain Summit
TOKYO, Sept. 26, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., participated in the three-day 11th Global Pharmaceutical Cold Chain Summit hosted by the China Federation of Logistics & Purchasing and held in Chongqing, China, from Wednesday, August 3, to Friday, August 5. Logo: https://kyodonewsprwire.jp/img/202209216879-O1-3438KR2G Photo1: Scene...
CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world’s premier diabetic foot conference (DFCon) in Los Angeles
- CRC data on cord lining media for the treatment of diabetic foot ulcers has been accepted at the DFCon, with Dr Wong Keng Lin Francis, CRC's latest KOL, presenting his findings to world leaders in the field of DFU.- Similarly, the results of Corlicyte™'s Phase 1 study on the treatment of...
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop “Off-the-Shelf” CAR-iMAC Cell Therapy
HANGZHOU, China, Sept. 26, 2022 /PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced it has made a global strategic collaboration agreement with Qilu Pharma to develop, manufacture and commercialize proprietary "off-the-shelf" induced pluripotent stem cell- (iPSC) derived Chimeric Antigen Receptor Macrophages (CAR-iMAC) for cancer immunotherapy. The collaboration will take advantages of technologies and expertise from both parties, as well...
Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases
Advancement highlights Everest's potential in providing first-in-class therapies to global patients with glomerular disease SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced today that the China National Medical Products Administration (NMPA)'s...
AAHRPP Accredits Five More Research Organizations, Including First in Japan
WASHINGTON, Sept. 24, 2022 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has accredited five more research organizations, including its first organization in Japan, two public research universities, a children's hospital and an acute-care hospital. At its September meeting, AAHRPP's Council on Accreditation awarded full accreditation to: ...
TCT2022| Pulnovo Medical Announced That The Latest Results Of PADN-CFDA Pivotal Trial Indicate Effectiveness And Safety of PADN For The Treatment Of Pulmonary Arterial Hypertension (PAH)
SHANGHAI, Sept. 23, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, today announced the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study on the world's largest and most influential American transcatheter cardiovascular therapy conference (TCT 2022). PADN is an innovative radiofrequency ablation technique in treating PH, was recognized as a CFDA innovative medical device in...
‘iSyncWave’ EEG Scanner receives FDA 510k clearance
SEOUL, South Korea, Sept. 23, 2022 /PRNewswire/ -- iMediSync announced that iSyncWave, the company's medical device EEG scanner, has been granted 510k clearance from the US Food and Drug Administration (FDA) on August 10th. iMediSync’s EEG scanner ‘iSyncWave’ has been FDA 510k cleared According to iMediSync, iSyncWave is a dry EEG scanner that does not require the use...
Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities
SINGAPORE, Sept. 23, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the official opening of its office and research facilities at the Singapore Science Park. Deputy Prime Minister and Coordinating Minister for Economic Policies Heng Swee Keat officiated the opening ceremony at The Galen on 23rd September...
Mentice AB (publ) receives an order of USD 620,000 for simulation solutions and development services
GOTHENBURG, Sweden, Sept. 23, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a leading global healthcare technology company, has signed an agreement to acquire Mentice VIST® simulation solutions and development services, for an order of USD 620,000. "Working with leading innovative partners, we value the opportunity to...
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
SHANGHAI, Sept. 23, 2022 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), consisting of three independent directors, Mr. Jian Sun, who is the chairman of the Special Committee, Mr. Nee Chuan Teo and Mr. Jun Luo, established by the...
